The Current Ratio as of June 2026 (TTM) for Panacos Pharmaceuticals, Inc. (PANC) is 5.47

According to Panacos Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.47. This represents a change of 48.58% compared to the average of 3.68 of the last 4 quarters.

Panacos Pharmaceuticals, Inc. (PANC) Historical Current Ratio (quarterly & annually)

How has PANC Current Ratio performed in the past?

The mean historical Current Ratio of Panacos Pharmaceuticals, Inc. over the last ten years is 4.99. The current 5.47 Current Ratio has changed 10.87% with respect to the historical average. Over the past ten years (40 quarters), PANC's Current Ratio was at its highest in in the March 2006 quarter at 18.68. The Current Ratio was at its lowest in in the March 2003 quarter at 0.93.

Panacos Pharmaceuticals, Inc. (PANC) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Panacos Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Panacos Pharmaceuticals, Inc. (PANC) Average Current Ratio

How has PANC Current Ratio performed in the past?

The current Current Ratio of Panacos Pharmaceuticals, Inc. (PANC) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Panacos Pharmaceuticals, Inc. (PANC) Current Ratio vs. Peers

How is PANC’s Current Ratio compared to its peers?

Panacos Pharmaceuticals, Inc.’s Current Ratio is greater than Arno Therapeutics, Inc. (0.08), greater than Oncology Pharma Inc. (0.00), greater than Better Therapeutics, Inc. (1.37), less than TetraLogic Pharmaceuticals Corporation (6.00), greater than Calithera Biosciences, Inc. (3.60), greater than Wuhan General Group (China), Inc. (3.18), greater than Innovation1 Biotech Inc. (0.02), greater than Kaleido Biosciences, Inc. (1.43), greater than Baudax Bio, Inc. (0.30), greater than Inyx, Inc. (0.45),

Build a custom stock screener for Panacos Pharmaceuticals, Inc. (PANC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Panacos Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Panacos Pharmaceuticals, Inc. (PANC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Panacos Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.